Erasca, Inc. Basic Shares Outstanding (Weighted Average)
Erasca, Inc. (ERAS) reported Basic Shares Outstanding (Weighted Average) of 311.34 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- Erasca, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 311.34M shares, a 9.87% increase year-over-year.
- Erasca, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 304.32M shares, a 7.43% increase year-over-year.
- Erasca, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 283.83M shares, a 0.22% increase year-over-year.
- Erasca, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 283.68M shares, a 0.46% increase year-over-year.
- Erasca, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 283.53M shares, a 21.26% increase from fiscal 2024.
- Erasca, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 233.82M shares, a 55.69% increase from fiscal 2023.
- Erasca, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 150.18M shares, a 23.08% increase from fiscal 2022.
- Erasca, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 122.02M shares, a 84.08% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 311.34M shares 10-Q · filed 2026-08-11 | 307.85M shares 10-Q · filed 2026-08-11 | 299.83M shares derived: average of 3 quarters · filed 2026-08-11 | 295.79M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 304.32M shares 10-Q · filed 2026-05-11 | 294.08M shares derived: average of 2 quarters · filed 2026-05-11 | 290.61M shares derived: average of 3 quarters · filed 2026-05-11 | 288.80M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | 283.83M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 283.76M shares derived: average of 2 quarters · filed 2026-03-12 | 283.62M shares derived: average of 3 quarters · filed 2026-08-11 | 283.53M shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 283.68M shares 10-Q · filed 2025-11-12 | 283.52M shares derived: average of 2 quarters · filed 2026-08-11 | 283.43M shares 10-Q · filed 2025-11-12 | 283.38M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | 283.36M shares 10-Q · filed 2026-08-11 | 283.31M shares 10-Q · filed 2026-08-11 | 283.27M shares derived: average of 3 quarters · filed 2026-08-11 | 283.05M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | 283.26M shares 10-Q · filed 2026-05-11 | 283.23M shares derived: average of 2 quarters · filed 2026-05-11 | 282.95M shares derived: average of 3 quarters · filed 2026-05-11 | 266.66M shares derived: average of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | 283.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 282.79M shares derived: average of 2 quarters · filed 2026-03-12 | 261.13M shares derived: average of 3 quarters · filed 2026-03-12 | 233.82M shares 10-K · filed 2026-03-12 |
| 2024-09-30 | 282.38M shares 10-Q · filed 2025-11-12 | 250.10M shares derived: average of 2 quarters · filed 2025-11-12 | 217.36M shares 10-Q · filed 2025-11-12 | 200.52M shares derived: average of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | 217.81M shares 10-Q · filed 2025-08-12 | 184.48M shares 10-Q · filed 2025-08-12 | 173.24M shares derived: average of 3 quarters · filed 2025-08-12 | 167.54M shares derived: average of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | 151.16M shares 10-Q · filed 2025-05-13 | 150.95M shares derived: average of 2 quarters · filed 2025-05-13 | 150.78M shares derived: average of 3 quarters · filed 2025-05-13 | 150.60M shares derived: average of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | 150.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 150.59M shares derived: average of 2 quarters · filed 2025-03-20 | 150.41M shares derived: average of 3 quarters · filed 2025-03-20 | 150.18M shares 10-K · filed 2025-03-20 |
| 2023-09-30 | 150.45M shares 10-Q · filed 2024-11-12 | 150.24M shares derived: average of 2 quarters · filed 2024-11-12 | 150.00M shares 10-Q · filed 2024-11-12 | 144.40M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | 150.04M shares 10-Q · filed 2024-08-12 | 149.77M shares 10-Q · filed 2024-08-12 | 142.38M shares derived: average of 3 quarters · filed 2024-08-12 | 136.99M shares derived: average of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | 149.50M shares 10-Q · filed 2024-05-08 | 138.55M shares derived: average of 2 quarters · filed 2024-05-08 | 132.63M shares derived: average of 3 quarters · filed 2024-05-08 | 129.52M shares derived: average of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | 127.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | 124.20M shares derived: average of 2 quarters · filed 2024-03-27 | 122.86M shares derived: average of 3 quarters · filed 2024-03-27 | 122.02M shares 10-K · filed 2024-03-27 |
| 2022-09-30 | 120.80M shares 10-Q · filed 2023-11-09 | 120.50M shares derived: average of 2 quarters · filed 2023-11-09 | 120.17M shares 10-Q · filed 2023-11-09 | 119.97M shares derived: average of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | 120.19M shares 10-Q · filed 2023-08-10 | 119.84M shares 10-Q · filed 2023-08-10 | 119.70M shares derived: average of 3 quarters · filed 2023-08-10 | 114.56M shares derived: average of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | 119.49M shares 10-Q · filed 2023-05-15 | 119.45M shares derived: average of 2 quarters · filed 2023-05-15 | 112.68M shares derived: average of 3 quarters · filed 2023-05-15 | 90.39M shares derived: average of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | 119.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | 109.27M shares derived: average of 2 quarters · filed 2023-03-23 | 80.69M shares derived: average of 3 quarters · filed 2023-03-23 | 66.29M shares 10-K · filed 2023-03-23 |
| 2021-09-30 | 99.13M shares 10-Q · filed 2022-11-09 | 61.34M shares derived: average of 2 quarters · filed 2022-11-09 | 48.58M shares 10-Q · filed 2022-11-09 | |
| 2021-06-30 | 23.55M shares 10-Q · filed 2022-08-11 | 22.89M shares 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |